Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,524.16
    +284.63 (+0.41%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.37
    +20.39 (+0.26%)
     
  • Gold

    2,230.40
    +17.70 (+0.80%)
     
  • Crude Oil

    82.57
    +1.22 (+1.50%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.

This Dividend Stock Will Rise by 20%, Per Wall Street. Here's Why You Should Sell It.

Sabra Health Care REIT (NASDAQ: SBRA) is slated to grow by quite a bit, for a real estate business at least. The average of the estimates made by Wall Street analysts suggests that Sabra's stock price will climb by around 20% over the year from its current level of around $11.27 to reach roughly $13.58. As its name implies, Sabra is a real estate investment trust (REIT) that buys and rents out healthcare properties like behavioral health clinics, skilled nursing facilities, and even senior housing using sale-leaseback transactions, among other types of deals.